Biotech | October 11, 2022
Panacea Biotec bags US $127.30 mn for supply of Pentavalent Vaccine
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
-0001_256_384.jpg){kind=logo}
The eyecirque under eye skin brightening supplement is a unique composition of scientifically proven essential antioxidants, vitamins and minerals
The companies have also initiated a Phase 1/2/3 study NCT05543616 to evaluate the safety, tolerability, and immunogenicity of different doses
Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from second-line (2L) and third-line (3L) ER+/HER2- advanced or metastatic breast cancer in the European Union
Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
Merck’s first microbiology application and training lab in India
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
Subscribe To Our Newsletter & Stay Updated
